^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
ColoSTAT®

Type:
CE Marked

Details

Evidence
ColoSTAT® is indicated to screen adults, aged 40 to 85, at average risk for developing CRC. The test-kit measures five specific biomarkers in the blood that either increase or decrease in quantity when CRC tumours are present. Generated data, along with the individual's age and sex, are entered into the ColoSTAT® proprietary algorithm software to produce a CRC ‘likelihood score’.
Cancer:
Colorectal Cancer
Approvals
Date
Cancer
Gene
Drug
By
11/30/21
CE